CCNE1 and gastric adenocarcinoma: We identified CCNE1 amplification in 6.2% of EA, 7.0% of EJC, and 4.2% of gastric adenocarcinoma samples; by contrast, CCNE1 was rarely amplified in ESCC (0.8%; Fig. 1B).